Internal Medicine, Hematology & Oncology · Jacksonville, FL
NPI
1710982822
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2 Shircliff Way, Ste 800
Jacksonville, FL, 32204
Phone (904) 388-2619
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
82,547 services
Medicare patients, 2024
473
Average age 76
Drug cost, 2024
$3.4M
1,207 prescriptions
Company payments, 2025
$300
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas S Davis was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 15,300 times for 14 patients. In total Thomas S Davis billed 82,547 services in 97 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 15,300 | 14 | $2.33 | $36K |
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 14 | $20.19 | $29K |
| 36415 Venipuncture Blood Collection | Office | 1,187 | 355 | $8.64 | $10K |
| 85025 Blood Count | Office | 1,022 | 330 | $7.61 | $7,777 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 736 | 15 | $0.09 | $66.07 |
| 99213 Office E&M - Established | Office | 406 | 237 | $62.44 | $25K |
| 99214 Office E&M - Established | Office | 405 | 161 | $93.51 | $38K |
| 96413 Chemotherapy Administration | Office | 179 | 24 | $92.37 | $17K |
| 96372 Injection Administration | Office | 153 | 35 | $10.57 | $1,617 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 95 | $12.81 | $1,755 |
| 96367 Intravenous Infusion, Hydration | Office | 137 | 15 | $21.28 | $2,915 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 114 | 20 | $69.37 | $7,909 |
| 85027 Blood Count | Office | 80 | 26 | $6.34 | $507 |
| 85007 Blood Count | Office | 77 | 26 | $3.72 | $286 |
| 99232 Hospital E&M - Subsequent | Facility | 76 | 47 | $60.67 | $4,611 |
By year: 2022 $1.3M for 125,635 services; 2023 $1.2M for 71,372 services; 2024 $1.5M for 82,547 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,187 | 355 | $8.64 | $10K |
| 85025 Blood Count | 1,022 | 330 | $7.61 | $7,777 |
| 85027 Blood Count | 80 | 26 | $6.34 | $507 |
| 85007 Blood Count | 77 | 26 | $3.72 | $286 |
| 85610 Clinical Chemistry | 73 | 14 | $4.20 | $307 |
| 85045 Blood Count | 36 | 31 | $3.91 | $141 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas S Davis prescribed most often to Medicare patients was Anastrozole, with 100 prescriptions and refills. In total Thomas S Davis wrote 1,207 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 100 | 276 | 32 | $2,576 |
| Alendronate Sodium Generic | 86 | 205 | 25 | $888 |
| Oxycodone Hcl Generic | 78 | 78 | 24 | $1,648 |
| Eliquis Apixaban | 60 | 136 | 24 | $79K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 | 47 | 28 | $1,350 |
| Ondansetron Odt Ondansetron | 38 | 38 | 27 | $774 |
| Valacyclovir Valacyclovir Hcl | 36 | 56 | 12 | $994 |
| Xarelto Rivaroxaban | 33 | 69 | 11 | $38K |
| Hydroxyurea Generic | 30 | 64 | Under 11 | $1,110 |
| Imbruvica Ibrutinib | 30 | 30 | Under 11 | $485K |
| Prochlorperazine Maleate Generic | 29 | 30 | 25 | $925 |
| Sps Sodium Polystyrene Sulfon/Sorb | 27 | 27 | 21 | $1,354 |
| Azithromycin Generic | 25 | 25 | 19 | $103 |
| Ondansetron Hcl Generic | 23 | 23 | 12 | $199 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 22 | 22 | 20 | $264 |
Brand drugs: 284 claims; generic drugs: 923 claims; opioid claims: 184.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas S Davis $300 ($300 in general payments such as food, travel and fees) from 10 companies. The largest payer was Pfizer Inc. with $92.23.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $92.23 |
| Janssen Biotech, Inc. JNJ | 2 | $34.19 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $29.81 |
| Eisai Inc. 4523.T | 2 | $28.28 |
| Tempus AI, Inc TEM | 1 | $27.68 |
| Merck Sharp & Dohme LLC MRK | 1 | $26.24 |
| Sobi, Inc SOBI.ST | 1 | $16.74 |
| EMD Serono, Inc. MRK.DE | 1 | $15.31 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $15.29 |
| Genentech USA, Inc. ROG.SW | 1 | $14.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.